Search Results
Search for other papers by S. Lausson in
Google Scholar
PubMed
Search for other papers by N. Segond in
Google Scholar
PubMed
Search for other papers by G. Milhaud in
Google Scholar
PubMed
Search for other papers by J. F. Staub in
Google Scholar
PubMed
ABSTRACT
The daily changes in rat thyroid calcitonin and its specific mRNA concentrations, and the relationship between their dynamics and the plasma levels of calcitonin, calcium and phosphate over a 24-h period were investigated. The circulating calcitonin concentration rose during the daily dark period when plasma calcium and phosphate levels were minimal, indicating that plasma calcitonin rhythm cannot be generated directly by a linear effect of calcium on hormone secretion. Moreover, we established that the expression of the calcitonin gene also exhibited periodic dynamics observable at the pretranslational level: the gland content of hybridizable specific calcitonin RNA displayed daily rhythms; specific RNA levels peaked during the light period and were minimal during the first part of the dark period. Significant changes in thyroid calcitonin concentrations also occurred over a 24-h period. Statistical analyses which distinguished between variations over the 24-h period and residual variations were performed to test the relationships between the various parameters. The daily rhythms of hybridizable RNA, thyroid calcitonin and plasma minerals appeared to be in phase, while the plasma calcitonin concentration displayed variations out of phase with these rhythms. The implication of the correlations observed on the residual variations is discussed in comparison with the temporal relationship between the daily variations. The results fit the hypothesis that hormone production and secretion are self-oscillating processes. Plasma concentrations of calcium and phosphate might play a role in the synchronization of the calcitonin metabolism periodicity.
Journal of Endocrinology (1989) 122, 527–534
Search for other papers by J Liu in
Google Scholar
PubMed
Search for other papers by R Voutilainen in
Google Scholar
PubMed
Search for other papers by A I Kahri in
Google Scholar
PubMed
Search for other papers by P Heikkilä in
Google Scholar
PubMed
Abstract
Abundant c-myc gene expression in neoplasms has been often linked to poor prognosis. As c-myc mRNA is expressed and hormonally regulated in human adrenals, we examined the c-myc gene expression in adrenal tumors by RNA analysis and immunohistochemistry to find out the possible role of c-myc in adrenal neoplasms. The abundant expression of the c-myc gene in normal adrenals was localized to the zona fasciculata and zona reticularis, with much lower expression in the zona glomerulosa and adrenal medulla. In hormonally active adrenocortical carcinomas (n=6) and in virilizing adenomas (n=4), c-myc mRNA levels were approximately 10% of those in normal adrenals (n=11). In contrast, adrenal adenomas from patients with Cushing's (n=4) and Conn's (n=9) syndrome, non-functional adenomas (n=2), adrenocortical hyperplasias (bilateral, n=5; nodular, n=4), and non-functional adrenocortical carcinomas (n=3) expressed c-myc mRNA to the same extent as normal adrenals. The c-myc mRNA abundance in benign adrenal pheochromocytomas (n=19) was similar to that in normal adrenal medulla. However, in malignant adrenal pheochromocytomas (n=6), the average c-myc mRNA levels were approximately threefold that in benign adrenal pheochromocytomas. There was a good correlation between c-myc mRNA expression and immunohistochemical reactivity in both normal and pathological adrenal tissues. Southern blot analysis revealed no amplification or rearrangement of the c-myc gene in any of the adrenal tumors.
In conclusion, c-myc expression localized to zona fasciculata and reticularis in normal adrenals. Virilizing adenomas and hormonally active adrenocortical carcinomas expressed c-myc mRNA clearly less than the other adrenal neoplasms and normal adrenal tissue. On the other hand, malignant pheochromocytomas contained more c-myc mRNA than benign ones. Further studies are required to clarify the mechanisms and significance for the distinct expression pattern of the c-myc gene in different adrenal neoplasms.
Journal of Endocrinology (1997) 152, 175–181
Search for other papers by J. A. PHILLIPS III in
Google Scholar
PubMed
Search for other papers by W. G. BEAMER in
Google Scholar
PubMed
Search for other papers by A. BARTKE in
Google Scholar
PubMed
Restriction endonuclease analysis of genomic DNA was carried out for three types of dwarf mice (Little, Ames dwarf and Snell dwarf) that have genetic defects in GH expression. We found the GH genes to be present in homozygotes for each mutant allele as well as in their control litter-mates. These three types of dwarf mice may be useful in studying the molecular basis of inherited GH deficiency and as models for analogous genetic disorders of human GH expression.
Search for other papers by A. R. Clark in
Google Scholar
PubMed
Search for other papers by K. Docherty in
Google Scholar
PubMed
In the adult, the insulin gene is expressed exclusively in the β cells of the islets of Langerhans. In order to understand the mechanisms involved in this cell-specific gene expression better, it is necessary to look at the molecular events controlling islet cell ontogeny. Although the timing of expression of each hormone during embryogenesis has been well documented, the exact cell lineage relationship among different islet cell types is not known in detail. In the developing mouse pancreas, glucagon immunoreactivity appears at day 12 (E12), insulin at E14·5 and somatostatin at E17, while pancreatic polypeptide immunoreactivity appears after birth (Teitelman & Lee, 1987). In transgenic mice, hybrid insulin genes are initially expressed in all cells of the embryonic endocrine pancreas (Alpert et al. 1988), suggesting a common pluripotent progenitor stem cell. This conclusion is supported by the observation that cell lines derived from islet cell tumours express multiple pancreatic hormones
Search for other papers by G Binder in
Google Scholar
PubMed
Search for other papers by S Revskoy in
Google Scholar
PubMed
Search for other papers by D Gupta in
Google Scholar
PubMed
Abstract
The ontogenesis of GH gene expression in the pituitary gland and immune organs of rats was studied by in vitro amplification of GH mRNA using a specific reverse transcription-polymerase chain reaction. Samples were obtained after microsurgery and total RNA extraction of fetal, neonatal and adult rat tissues. Amplification was followed by analysis using Southern blot techniques and hybridization using a specific digoxigenin-labelled GH cDNA probe. The study was started on day 15 of gestation. GH gene expression occurred in the pituitary gland on day 17. GH mRNA was found in the bone marrow and thymus of neonatal rats but not in the spleen or liver. No GH transcripts were detected in the immune organs of fetal or adult rats. The transient GH expression in rat immune organs may indicate a specific function of GH in the development of the immune system during the neonatal period.
Journal of Endocrinology (1994) 140, 137–143
Search for other papers by Zhang S-L in
Google Scholar
PubMed
Search for other papers by X Chen in
Google Scholar
PubMed
Search for other papers by TJ Hsieh in
Google Scholar
PubMed
Search for other papers by M Leclerc in
Google Scholar
PubMed
Search for other papers by N Henley in
Google Scholar
PubMed
Search for other papers by A Allidina in
Google Scholar
PubMed
Search for other papers by JP Halle in
Google Scholar
PubMed
Search for other papers by MG Brunette in
Google Scholar
PubMed
Search for other papers by JG Filep in
Google Scholar
PubMed
Search for other papers by SS Tang in
Google Scholar
PubMed
Search for other papers by Ingelfinger JR in
Google Scholar
PubMed
Search for other papers by JS Chan in
Google Scholar
PubMed
Clinical and animal studies have shown that treatment with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II (Ang II) receptor antagonists slows the progression of nephropathy in diabetes, indicating that Ang II plays an important role in its development. We have reported previously that insulin inhibits the stimulatory effect of high glucose levels on angiotensinogen (ANG) gene expression in rat immortalized renal proximal tubular cells (IRPTCs) via the mitogen-activated protein kinase (p44/42 MAPK) signal transduction pathway. We hypothesize that the suppressive action of insulin on ANG gene expression might be attenuated in renal proximal tubular cells (RPTCs) of rats with established diabetes. Two groups of male adult Wistar rats were studied: controls and streptozotocin (STZ)-induced diabetic rats at 2, 4, 8 and 12 weeks post-STZ administration. Kidney proximal tubules were isolated and cultured in either normal glucose (i.e. 5 mM) or high glucose (i.e. 25 mM) medium to determine the inhibitory effect of insulin on ANG gene expression. Immunoreactive rat ANG (IR-rANG) in culture media and cellular ANG mRNA were measured by a specific radioimmunoassay and reverse transcription-polymerase chain reaction assay respectively. Activation of the p44/42 MAPK signal transduction pathway in rat RPTCs was evaluated by p44/42 MAPK phosphorylation employing a PhosphoPlus p44/42 MAPK antibody kit. Insulin (10(-7) M) inhibited the stimulatory effect of high glucose levels on IR-rANG secretion and ANG gene expression and increased p44/42 MAPK phosphorylation in normal rat RPTCs. In contrast, it failed to affect these parameters in diabetic rat RPTCs. In conclusion, our studies demonstrate that hyperglycaemia induces insulin resistance on ANG gene expression in diabetic rat RPTCs by altering the MAPK signal transduction pathway.
Search for other papers by D Santos Ornellas in
Google Scholar
PubMed
Search for other papers by R Grozovsky in
Google Scholar
PubMed
Search for other papers by RC Goldenberg in
Google Scholar
PubMed
Search for other papers by DP Carvalho in
Google Scholar
PubMed
Search for other papers by P Fong in
Google Scholar
PubMed
Search for other papers by WB Guggino in
Google Scholar
PubMed
Search for other papers by M Morales in
Google Scholar
PubMed
Thyroid hormones has its main role in controlling metabolism, but it can also modulate extracellular fluid Volume (ECFV) through its action on the expression and activity of Na(+) transporters. Otherwise, chloride is the main anion in the ECFV and the influence of thyroid hormones in the regulation of chloride transporters is not yet understood. In this work, we studied the effect of thyroid hormones in the expression of ClC-2, a cell Volume-, pH- and voltage-sensitive Cl(-) channel, in rat kidney. To analyze the modulation of ClC-2 gene expression by thyroid hormones, we used hypothyroid (Hypo) rats with or without thyroxine (T(4)) replacement and hyperthyroid (Hyper) rats as our experimental models. Total RNA was isolated and the expression of ClC-2 mRNA was evaluated by a ribonuclease protection assay, and/or semi-quantitative RT-PCR. Renal ClC-2 expression decreased in Hypo rats and increased in Hyper rats. In addition, semi-quantitative RT-PCR of different nephron segments showed that these changes were due exclusively to the modulation of ClC-2 mRNA expression by thyroid hormone in convoluted and straight proximal tubules. To investigate whether thyroid hormones action was direct or indirect, renal proximal tubule primary culture cells were prepared and subjected to different T(4) concentrations. ClC-2 mRNA expression was increased by T(4) in a dose-dependent fashion, as analyzed by RT-PCR. Western blotting demonstrated that ClC-2 protein expression followed the same profile of mRNA expression.
Search for other papers by P A Bennett in
Google Scholar
PubMed
Search for other papers by A Levy in
Google Scholar
PubMed
Search for other papers by S Sophokleous in
Google Scholar
PubMed
Search for other papers by I C A F Robinson in
Google Scholar
PubMed
Search for other papers by S L Lightman in
Google Scholar
PubMed
Abstract
GH synthesis and release from the anterior pituitary is governed by the opposing actions of somatostatin (SS) and GH-releasing factor (GRF), derived from the periventricular and arcuate nucleus (ARC) of the hypothalamus respectively. GH is known to regulate its own release by hypothalamic autofeedback mechanisms, but the extent to which this is a direct effect rather than indirectly via the generation of IGFs is still a subject of debate. GH receptors are known to be present in the hypothalamus, but their physiological regulation is poorly understood. We therefore used in situ hybridization histochemistry to investigate the effects of GH status on hypothalamic GH receptor gene expression, using hypophysectomized normal and dw/dw dwarf rats as models of acquired and congenital GH deficiency. Hypophysectomy resulted in a timedependent reduction in GH receptor gene expression. ARC GH receptor transcripts in untreated dw/dw dwarf rats were half those found in normal animals of the same background strain (16·8±1·7 vs 9·3± 1·9 d.p.m./mg, P<0·05). Increasing circulating GH by peripheral infusion of 200 μg human GH (hGH)/day for 6 days increased ARC GH receptor expression in dw/dw rats to normal. In contrast, central infusions of hGH at 26·4 and 79·2 μg/day for 6 days in normal rats lowered ARC GH receptor gene expression. The sensitivity of GH receptor gene expression within the central nervous system to peripheral and central GH levels suggests that feedback regulation of GRF and/or SS may be mediated directly by these receptors, and that the sensitivity to GH feedback is also subject to autoregulation by GH altering its own receptor expression.
Journal of Endocrinology (1995) 147, 225–234
Search for other papers by J Liu in
Google Scholar
PubMed
Search for other papers by R Voutilainen in
Google Scholar
PubMed
Search for other papers by A I Kahri in
Google Scholar
PubMed
Search for other papers by P Heikkilä in
Google Scholar
PubMed
Abstract
We have analyzed the expression of the c-myc proto-oncogene in human adrenal glands in vivo and in primary cell cultures by Northern blot analysis. c-myc mRNA was consistently expressed in all human adrenals studied. Expression in adult adrenals was found to be approximately 50% of that in fetal adrenals, but much higher than that in adult liver and kidney. Adrenocorticotropin (ACTH) treatment increased c-myc mRNA accumulation dose- and time-dependently up to more than 5-fold (on average), with the maximal effect at 2 h. (Bu)2cAMP and 12-O-tetradecanoyl phorbol 13-acetate (TPA) also induced c-myc gene expression. There was no synergistic effect between the ACTH, (Bu)2cAMP and TPA treatments. The basal level of c-myc expression was reduced by the protein kinase inhibitors H-7 (1-(5-isoquinolinesulfonyl)-2-methyl-piperazine dihydrochloride), staurosporine and HA1004 (N-(2-guanidinoethyl)-5-isoquinolinesulfonamide hydrochloride). H-7 totally abolished ACTH-, TPA- and (Bu)2cAMP-induced c-myc expression, while staurosporine inhibited the stimulatory effects of ACTH and TPA, and HA1004 weakly inhibited the effects of ACTH and (Bu)2cAMP. Incubation with cycloheximide or 10% fetal calf serum increased c-myc mRNA levels 3- and 4-fold respectively. Our data show that the c-myc gene is expressed abundantly in normal human adrenals, and that this expression can be regulated by multiple factors in the primary cultures.
Journal of Endocrinology (1996) 148, 523–529
Search for other papers by C K Glass in
Google Scholar
PubMed
Introduction
Retinoic acid and thyroid hormones regulate gene expression by binding to intracellular proteins that are members of the nuclear receptor superfamily of transcription factors. Members of this gene family activate transcription by binding to specific DNA sequences, termed response elements, that are generally located in the vicinity of target genes. Thyroid hormone receptors (TRs) and retinoic acid receptors (RARs) can exert either of two effects on the transcription of target genes. In the absence of ligand, both the RAR and TR strongly repress transcription from promoters to which they bind. In the presence of an activating ligand, this repressive effect is relieved and transcription is markedly stimulated. As a result, a very large dynamic range in the level of transcriptional activity can be achieved. Recognition of DNA response elements by nuclear receptors is mediated by a central, highly conserved DNA binding domain, while ligand binding, dimerization and transcriptional activation
